Abstract
Interleukin 17 (IL-17)-producing helper T cells (TH-17 cells), together with their effector cytokines, including members of the IL-17 family, are emerging as key mediators of chronic inflammatory and autoimmune disorders. Here we present the crystal structure of a complex of IL-17 receptor A (IL-17RA) bound to IL-17F in a 1:2 stoichiometry. The mechanism of complex formation was unique for cytokines and involved the engagement of IL-17 by two fibronectin-type domains of IL-17RA in a groove between the IL-17 homodimer interface. Binding of the first receptor to the IL-17 cytokines modulated the affinity and specificity of the second receptor-binding event, thereby promoting heterodimeric versus homodimeric complex formation. IL-17RA used a common recognition strategy to bind to several members of the IL-17 family, which allows it to potentially act as a shared receptor in multiple different signaling complexes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
195,33 € per year
only 16,28 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Mosmann, T.R. & Coffman, R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–173 (1989).
Harrington, L.E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005).
Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485–517 (2009).
Weaver, C.T., Hatton, R.D., Mangan, P.R. & Harrington, L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821–852 (2007).
Gaffen, S.L. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. (2009).
Hymowitz, S.G. et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. EMBO J. 20, 5332–5341 (2001).
Wright, J.F. et al. Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J. Biol. Chem. 282, 13447–13455 (2007).
Toy, D. et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J. Immunol. 177, 36–39 (2006).
Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282–289 (2008).
Ishigame, H. et al. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30, 108–119 (2009).
O'Connor, Jr W. et al. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10, 603–609 (2009).
Novatchkova, M., Leibbrandt, A., Werzowa, J., Neubuser, A. & Eisenhaber, F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem. Sci. 28, 226–229 (2003).
Kramer, J.M. et al. Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor. J. Immunol. 179, 6379–6383 (2007).
Maitra, A. et al. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression. Proc. Natl. Acad. Sci. USA 104, 7506–7511 (2007).
Rochman, Y., Spolski, R. & Leonard, W.J. New insights into the regulation of T cells by γc family cytokines. Nat. Rev. Immunol. 9, 480–490 (2009).
Claudio, E. et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J. Immunol. 182, 1617–1630 (2009).
Chang, S.H., Park, H. & Dong, C. Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor. J. Biol. Chem. 281, 35603–35607 (2006).
Qian, Y. et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat. Immunol. 8, 247–256 (2007).
Kramer, J.M. et al. Evidence for ligand-independent multimerization of the IL-17 receptor. J. Immunol. 176, 711–715 (2006).
Bazan, J.F. Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl. Acad. Sci. USA 87, 6934–6938 (1990).
Wright, J.F. et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J. Immunol. 181, 2799–2805 (2008).
Rickel, E.A. et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J. Immunol. 181, 4299–4310 (2008).
Shi, Y. et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J. Biol. Chem. 275, 19167–19176 (2000).
Lee, J. et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J. Biol. Chem. 276, 1660–1664 (2001).
Rong, Z. et al. IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling. Cell Res. 19, 208–215 (2009).
Wang, X., Lupardus, P., Laporte, S.L. & Garcia, K.C. Structural biology of shared cytokine receptors. Annu. Rev. Immunol. 27, 29–60 (2009).
He, X.L. & Garcia, K.C. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 304, 870–875 (2004).
Wehrman, T. et al. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 53, 25–38 (2007).
Gong, Y., Cao, P., Yu, H.J. & Jiang, T. Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex. Nature 454, 789–793 (2008).
Wiesmann, C. et al. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell 91, 695–704 (1997).
Wang, X., Baloh, R.H., Milbrandt, J. & Garcia, K.C. Structure of artemin complexed with its receptor GFRα3: convergent recognition of glial cell line-derived neurotrophic factors. Structure 14, 1083–1092 (2006).
Wiesmann, C., Ultsch, M.H., Bass, S.H. & de Vos, A.M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401, 184–188 (1999).
You, Z. et al. Interleukin-17 receptor-like gene is a novel antiapoptotic gene highly expressed in androgen-independent prostate cancer. Cancer Res. 66, 175–183 (2006).
Li, T.S., Li, X.N., Chang, Z.J., Fu, X.Y. & Liu, L. Identification and functional characterization of a novel interleukin 17 receptor: a possible mitogenic activation through ras/mitogen-activated protein kinase signaling pathway. Cell. Signal. 18, 1287–1298 (2006).
LaPorte, S.L. et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 132, 259–272 (2008).
Dukkipati, A., Park, H.H., Waghray, D., Fischer, S. & Garcia, K.C. BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies. Protein Expr. Purif. 62, 160–170 (2008).
Walter, T.S. et al. Lysine methylation as a routine rescue strategy for protein crystallization. Structure 14, 1617–1622 (2006).
Barton, W.A., Tzvetkova-Robev, D., Erdjument-Bromage, H., Tempst, P. & Nikolov, D.B. Highly efficient selenomethionine labeling of recombinant proteins produced in mammalian cells. Protein Sci. 15, 2008–2013 (2006).
Leslie, A.G.W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newsletter on Protein Crystallography 26 (1992).
Collaborative Computation Project 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50, 760–763 (1994).
Strong, M. et al. Toward the structural genomics of complexes: crystal structure of a PE/PPE protein complex from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 103, 8060–8065 (2006).
McCoy, A.J. et al. Phaser crystallographic software. J. Appl. Crystallogr. 40, 658–674 (2007).
de La Fortelle, E. & Bricogne, G. SHARP: A maximum-likelihood heavy-atom parameter refinement program for the MIR and MAD methods. Methods Enzymol. 276, 472–494 (1997).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004).
Afonine, P.V., Grosse-Kunstleve, R.W. & Adams, P.D. The Phenix refinement framework. CCP4 Newsletter 42 (2005).
Brunger, A.T. Version 1.2 of the Crystallography and NMR system. Nat. Protoc. 2, 2728–2733 (2007).
Laskowski, R.A., Moss, D.S. & Thornton, J.M. Main-chain bond lengths and bond angles in protein structures. J. Mol. Biol. 231, 1049–1067 (1993).
Hooft, R.W., Vriend, G., Sander, C. & Abola, E.E. Errors in protein structures. Nature 381, 272 (1996).
DeLano, W.L. Pymol Molecular Graphics System (DeLano Scientific, San Carlos, California, 2002).
Acknowledgements
We thank S. Juo for assistance with data collection and structure determination; E. Özkan for discussions; D. Gorman (DNAX) for cDNA reagents; and the beamline staff of the Stanford Synchrotron Radiation Lightsource, Advanced Light Source and Advanced Photon Source for assistance with data collection. Supported by the National Health and Medical Research Council of Australia (L.K.E.), the US National Institutes of Health (AI51321 to K.C.G.) and the Howard Hughes Medical Institute (K.C.G.).
Author information
Authors and Affiliations
Contributions
K.C.G. initiated studies; L.K.E. and K.C.G. designed experiments; L.K.E. and S.F. did experiments; and L.K.E. and K.C.G. analyzed data and wrote manuscript.
Corresponding author
Ethics declarations
Competing interests
K.C.G. plans to file a patent to use information gained from this crystal structure to design IL-17 therapeutics.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–3 (PDF 315 kb)
Rights and permissions
About this article
Cite this article
Ely, L., Fischer, S. & Garcia, K. Structural basis of receptor sharing by interleukin 17 cytokines. Nat Immunol 10, 1245–1251 (2009). https://doi.org/10.1038/ni.1813
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.1813
This article is cited by
-
Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis
Military Medical Research (2022)
-
Local and systemic effects of IL-17 in joint inflammation: a historical perspective from discovery to targeting
Cellular & Molecular Immunology (2021)
-
Protein–protein interaction and in silico mutagenesis studies on IL17A and its peptide inhibitor
3 Biotech (2021)
-
The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties
Scientific Reports (2017)
-
IL-17 is a neuromodulator of Caenorhabditis elegans sensory responses
Nature (2017)